Synthesis, Crystal Structure and Biological Activity of Ethyl 5-(4-Fluorophenyl)-7-(trifluoromethyl)-pyrazolo[1,5-a]pyrimidine-3-carboxylate

The title compound, C16H11F4N3O2, was synthesized and structurally characterized by elemental analysis, IR, MS, H-1-NMR and single-crystal X-ray diffraction. This compound has a pyrazolo[1,5-a]pyrimidine skeleton, and it crystallizes in monoclinic system, space group P2(1)/c with a = 20.8547(12), b = 20.5558(10), c = 7.1575(4) angstrom, beta = 96.610(5)degrees, V = 3047.9(3) angstrom(3), Z = 4, D-c = 1.540 g.cm(-3), F(000) = 1440, mu(MoK alpha) = 0.14 mm(-1), R = 0.0546 and wR = 0.1276 for 5370 reflections with I > 2 sigma(I). In addition, biological activity determination results indicated that the title compound exhibited poor inhibitory activity on MKN45 and H460 cancer cell lines.